Thanks for taking the time to visit China Med Device at the RAPS Convergence in Vancouver. I appreciate the opportunity to share some of the latest developments at NMPA (CFDA) at our exhibit booth and during the China plenary session. China Med Device provides turnkey solutions for China RA/QA/CRO and commercialization in medical device/IVD/combination products to ensure shortest time to market. For slides on Practical CFDA Compliant Clinical Trial Tips in China in 2018 that we shared on RAPS please email info@ChinaMedDevice.com.
China Med Device, LLC (www.ChinaMedDevice.com), a Boston headquartered company, provides regulatory and commercialization turnkey solutions for western medical device, IVD and combination-product companies to enter China. Our NMPA (CFDA) regulatory services include: regulatory strategy, RA, clinical evaluation, clinical trial, QA, GMP and post-market compliance. Our commercialization services include: market assessment research, reimbursement, partnership, distribution qualification and management. We are a NMPA (CFDA) certified legal agent. With offices in U.S. (Boston) and China (Beijing), we can service our clients 24/7.
Please feel free to connect with me on LinkedIn https://www.linkedin.com/in/gracefupalma/. Please opt-in for the CFDA News Roundup from China Med Device, LLC (https://ChinaMedDevice.com/category/cfda-updates/).